Literature DB >> 11747665

Telemedicine and clinical genetics: establishing a successful service.

M R Gattas1, J C MacMillan, I Meinecke, M Loane, R Wootton.   

Abstract

There is a surprising lack of published experience on the use of videoconferencing in clinical genetics. Patients were randomly allocated to either a telegenetic (cases) or face-to-face (control) conventional clinic. The telegenetic consultation was done by videoconferencing, using ISDN lines at 384 kbit/s. Evaluation by the doctor and counsellor took place immediately after each appointment. The patient was asked to evaluate the appointment by telephone questionnaire about four weeks after the event. Forty-two patients were invited to participate and 33 (79%) returned their consent forms. Four patients declined to participate and were seen in ordinary face-to-face clinics. Preliminary results showed that the assessment of the telegenetics consultations by doctors, counsellors and patients was very favourable, and they responded positively when asked if they would be happy to use telemedicine in the future. For use in selected consultations, videoconferencing does appear to fulfil a useful role in clinical genetics.

Entities:  

Mesh:

Year:  2001        PMID: 11747665     DOI: 10.1258/1357633011937191

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  19 in total

1.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

2.  Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.

Authors:  A R Bradbury; L Patrick-Miller; D Fetzer; B Egleston; S A Cummings; A Forman; L Bealin; C Peterson; M Corbman; J O'Connell; M B Daly
Journal:  Clin Genet       Date:  2010-10-12       Impact factor: 4.438

3.  Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.

Authors:  Neal J Meropol; Mary B Daly; Hetal S Vig; Frank J Manion; Sharon L Manne; Carla Mazar; Camara Murphy; Nicholas Solarino; Vadim Zubarev
Journal:  J Telemed Telecare       Date:  2010-11-19       Impact factor: 6.184

4.  Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.

Authors:  Ellen Otten; Erwin Birnie; Adelita V Ranchor; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

5.  Telegenetics: an Update on Availability and Use of Telemedicine in Clinical Genetics Service.

Authors:  Irena Vrečar; Dimitar Hristovski; Borut Peterlin
Journal:  J Med Syst       Date:  2016-12-17       Impact factor: 4.460

6.  Implementing a Virtual Health Telemedicine Program in a Community Setting.

Authors:  Scott M Weissman; Kate Zellmer; Nicole Gill; Deborah Wham
Journal:  J Genet Couns       Date:  2017-12-04       Impact factor: 2.537

7.  Genetic Counselors' Experiences and Interest in Telegenetics and Remote Counseling.

Authors:  Heather A Zierhut; Ian M MacFarlane; Zahra Ahmed; Jill Davies
Journal:  J Genet Couns       Date:  2018-01-23       Impact factor: 2.537

8.  A comparison of patient satisfaction with telehealth and on-site consultations: a pilot study for prenatal genetic counseling.

Authors:  Debra J Abrams; Mark R Geier
Journal:  J Genet Couns       Date:  2006-06       Impact factor: 2.537

Review 9.  Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).

Authors:  Linda Patrick-Miller; Angela R Bradbury; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

10.  Impact of delivery models on understanding genomic risk for type 2 diabetes.

Authors:  S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg
Journal:  Public Health Genomics       Date:  2014-02-27       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.